MarketWatch

AirNexis Therapeutics Launches with $200M Series A to Advance Phase 2 Dual PDE3/4 Inhibitor AN01 for Chronic Obstructive Pulmonary Disease (COPD)

The MarketWatch News Department was not involved in the creation of this content. AirNexis acquires exclusive rights to develop AN01 outside of China from Haisco Pharmaceutical Group Company founded ...
Yahoo Finance

M&G (Lux) Investment Funds 1 - M&G (Lux) Global Emerging Markets Fund (AN01.F)

Find the latest M&G (Lux) Investment Funds 1 - M&G (Lux) Global Emerging Markets Fund (AN01.F) stock quote, history, news and other vital information to help you with your stock trading and investing.
London South East

AN01.L Share Price (AN01)

Citigroup Global Markets Funding Luxembourg S.c.a. Wrst Fxd Cpn Atcl Nts Lk is listed on the London Stock Exchange trading with ticker code AN01.L. It has a market capitalisation of -, with ...
Yahoo Finance

M+G(L)I1-G.E.M DLAA (AN01.BE)

Find the latest M+G (L)I1-G.E.M DLAA (AN01.BE) stock quote, history, news and other vital information to help you with your stock trading and investing.
PharmiWeb

AirNexis Therapeutics Launches with $200M Series A to Advance Phase 2 Dual PDE3/4 Inhibitor AN01 for Chronic Obstructive Pulmonary Disease (COPD)

Company founded by Frazier Life Sciences, which led the Series A financing with participation from OrbiMed, Life Sciences at Goldman Sachs Alternatives, SR One, Longitude Capital and Enavate Sciences ...
Yahoo Finance

M+G(L)I1-G.E.M DLAA (AN01.MU)

Find the latest M+G (L)I1-G.E.M DLAA (AN01.MU) stock quote, history, news and other vital information to help you with your stock trading and investing.